166 related articles for article (PubMed ID: 15184024)
1. Directed evolution of soluble single-chain human class II MHC molecules.
Esteban O; Zhao H
J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
[TBL] [Abstract][Full Text] [Related]
2. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
3. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens.
Kieke MC; Sundberg E; Shusta EV; Mariuzza RA; Wittrup KD; Kranz DM
J Mol Biol; 2001 Apr; 307(5):1305-15. PubMed ID: 11292343
[TBL] [Abstract][Full Text] [Related]
4. Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro.
Frayser M; Sato AK; Xu L; Stern LJ
Protein Expr Purif; 1999 Feb; 15(1):105-14. PubMed ID: 10024477
[TBL] [Abstract][Full Text] [Related]
5. Directed evolution of a stable scaffold for T-cell receptor engineering.
Shusta EV; Holler PD; Kieke MC; Kranz DM; Wittrup KD
Nat Biotechnol; 2000 Jul; 18(7):754-9. PubMed ID: 10888844
[TBL] [Abstract][Full Text] [Related]
6. Cooperativity during the formation of peptide/MHC class II complexes.
Anderson MW; Gorski J
Biochemistry; 2005 Apr; 44(15):5617-24. PubMed ID: 15823020
[TBL] [Abstract][Full Text] [Related]
7. A site for CD4 binding in the beta 1 domain of the MHC class II protein HLA-DR1.
Brogdon J; Eckels DD; Davies C; White S; Doyle C
J Immunol; 1998 Nov; 161(10):5472-80. PubMed ID: 9820523
[TBL] [Abstract][Full Text] [Related]
8. Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity.
Chaves FA; Hou P; Wu S; Sant AJ
J Immunol Methods; 2005 May; 300(1-2):74-92. PubMed ID: 15896797
[TBL] [Abstract][Full Text] [Related]
9. Peptide binding inhibits aggregation of soluble MHC class II in solution.
Arimilli S; Astafieva I; Mukku PV; Cardoso C; Deshpande S; Nag B
IUBMB Life; 1999 Nov; 48(5):483-91. PubMed ID: 10637763
[TBL] [Abstract][Full Text] [Related]
10. MHC class I/peptide interactions: binding specificity and kinetics.
Margulies DH; Corr M; Boyd LF; Khilko SN
J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
[TBL] [Abstract][Full Text] [Related]
11. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
12. A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding.
Zarutskie JA; Sato AK; Rushe MM; Chan IC; Lomakin A; Benedek GB; Stern LJ
Biochemistry; 1999 May; 38(18):5878-87. PubMed ID: 10231540
[TBL] [Abstract][Full Text] [Related]
13. Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.
Xu M; Jackson R; Adams S; Humphreys RE
Arzneimittelforschung; 1999 Sep; 49(9):791-9. PubMed ID: 10514908
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
Menz B; Sester M; Koebernick K; Schmid R; Burgert HG
Mol Immunol; 2008 Nov; 46(1):16-26. PubMed ID: 18692902
[TBL] [Abstract][Full Text] [Related]
15. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
[TBL] [Abstract][Full Text] [Related]
16. Yeast surface display of a noncovalent MHC class II heterodimer complexed with antigenic peptide.
Boder ET; Bill JR; Nields AW; Marrack PC; Kappler JW
Biotechnol Bioeng; 2005 Nov; 92(4):485-91. PubMed ID: 16155952
[TBL] [Abstract][Full Text] [Related]
17. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
Neumann J; Koch N
J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
[TBL] [Abstract][Full Text] [Related]
18. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
[TBL] [Abstract][Full Text] [Related]
19. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
[TBL] [Abstract][Full Text] [Related]
20. Rapid identification of CD4+ T-cell epitopes using yeast displaying pathogen-derived peptide library.
Wen F; Esteban O; Zhao H
J Immunol Methods; 2008 Jul; 336(1):37-44. PubMed ID: 18448115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
